NexGel, Inc.
NXGL • NASDAQ
NexGel, Inc. is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO Adam R. Levy, with a market cap of $5.4M.
CEOAdam R. Levy
Next Earnings
Upcoming earnings announcement for NexGel, Inc.
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.03
Revenue Estimate
$3.2M
Earnings History
Past 11 earnings reports for NexGel, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 11, 2025 | Q3 2025 | -$0.08Est: -$0.08 | 0.0% | $2.9MEst: $3.2M | -7.4% |  10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.09Est: -$0.07 | -28.6% | $2.9MEst: $3.1M | -6.4% | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.09Est: -$0.10 | +10.0% | $2.8MEst: $2.7M | +2.8% | 10-Q |
| Mar 24, 2025 | Q4 2024 | -$0.11Est: -$0.13 | +15.4% | $3.0MEst: $3.0M | +1.7% | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.11Est: -$0.10 | -10.0% | $2.9MEst: $2.9M | +3.2% | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.14Est: -$0.14 | 0.0% | $1.4MEst: $1.4M | +2.9% | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.14Est: -$0.18 | +22.2% | $1.3MEst: $1.2M | +4.6% | 10-Q |
| Apr 1, 2024 | Q4 2023 | -$0.20Est: -$0.11 | -81.8% | $1.1MEst: $1.4M | -21.6% | 10-K |
| Nov 13, 2023 | Q3 2023 | -$0.10 | — | $1.2M | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.13 | — | $1.2M | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.15 | — | $620.0K | — | — |